Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer

NCT00003860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: carboplatin
DRUG: etoposide
DRUG: ifosfamide
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation

Sponsor

UNICANCER